NWI Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-600,000
Closed -$52.6M 31
2018
Q1
$52.6M Buy
+600,000
New +$54.8M 4.41% 8

Other funds holding XBI

NWI Management's XBI Position: Q2 2018 in Review

NWI Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 600,000 shares — an estimated $52.6M sold.

NWI Management first reported a position in XBI in Q1 2018 and held it in 1 quarter. The position peaked at $52.6M in Q1 2018. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

  • NWI Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
  • NWI Management sold 600,000 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $52.6M.
  • NWI Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 1 quarter.
  • NWI Management's State Street SPDR S&P Biotech ETF position peaked at $52.6M in Q1 2018.
  • 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on NWI Management's 13F filing for Q2 2018, filed 14 Aug 2018.